Prevention of severe adverse reactions after iodinated contrast media injection: Literature review;Prévention des réactions sévères après injection de produits de contraste iodés: Revue de la littérature

Journal de Radiologie

Volumn 84, Issue 5, 2003, Pages 535-544

  Dewachter, P ^a   Mouton Faivre, C ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Adverse drug reaction; Allergy; Contrast media; Hypersensitivity, allergy; Hypersensitivity, immediate; Iodine; Premedication

Indexed keywords

ATROPINE; CIMETIDINE; CLEMASTINE; CORTANCY; DIPHENHYDRAMINE; EPHEDRINE; GLUCOCORTICOID; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYZINE; IODINATED CONTRAST MEDIUM; MEGLUMINE IOXAGLATE PLUS SODIUM IOXAGLATE; METHYLPREDNISOLONE; NIZATIDINE; PREDNISOLONE 3 SULFOBENZOATE; PREDNISONE; PREDNISONE ACETATE; PSEUDOEPHEDRINE PLUS TRIPROLIDINE; QUINIDINE; RANITIDINE; TRANEXAMIC ACID;

ANAPHYLAXIS; ANGIONEUROTIC EDEMA; BRONCHOSPASM; CLINICAL TRIAL; CONTRAST ENHANCEMENT; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; EPIDEMIOLOGICAL DATA; FACE EDEMA; HIGH RISK PATIENT; HUMAN; HYPOTENSION; IMMUNOGLOBULIN BLOOD LEVEL; INJECTION; INTRACUTANEOUS TEST; PATHOPHYSIOLOGY; PREMEDICATION; RANDOMIZATION; REVIEW; RISK ASSESSMENT; SKIN MANIFESTATION; URTICARIA;

ANTI-INFLAMMATORY AGENTS; CONTRAST MEDIA; DRUG HYPERSENSITIVITY; EVIDENCE-BASED MEDICINE; HISTAMINE H1 ANTAGONISTS; HUMANS; HYPERSENSITIVITY, IMMEDIATE; INJECTIONS, INTRAVENOUS; INTRADERMAL TESTS; IODINE COMPOUNDS; PREMEDICATION; RADIOLOGY; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0038304482     PISSN: 02210363     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (109)

1. Katayama H, Yamaguchi K, Kozucka T, Takashima T, Seez P, Matsuura K. Adverse reactions to ionic and nonionic contrast media. Radiology 1990;175: 621-8.
2. Laxenaire MC and the members of the Writing Committee. Drugs and other agents involved in anaphylactic shock occurring during anaesthesia. A french multicenter epidemiological inquiry. Ann Fr Anesth Reanim 1993;12:91-6.
3. Laxenaire MC, Mertes PM and Groupe d'études des réactions anaphylactoides peranesthésiques. Anaphylaxis during anaesthesia. Results of a two-year survey in France. Br J Anaesth 2001; 87:549-58.
4. Laxenaire MC, Moneret-Vautrin DA, Widmer S, Mouton-Faivre C, Guéant JL. Substances anesthésiques responsables de chocs anaphylactiques. Enquête multicentrique française Ann Fr Anesth Reanim 1990;9:501-6.
5. Laxenaire MC. Substances responsables des chocs anaphylactoides peranesthésiques. Troisième enquête multicentrique française (1991-1994). Ann Fr Anesth Reanim 1996;15:1211-8.
6. Laxenaire MC et le Groupe d'études des réactions anaphylactoides peranesthésiques, Epidémiologie des réactions anaphylactoides peranesthésiques. Quatrième enquête multicentrique française (juillet 1994-décembre 1996). Ann Fr Anesth Reanim 1999;18: 796-809.
7. Décret n° 95-278 relatif à la pharmacovigilance et modifiant le Code de la santé publique. JO du 14 mars 1995.
8. Dolan L, Toledo M. Allergic death due to intravenous use of diodrast JAMA 1940;114:138-9.
9. Goldburgh H, Baer S. Death following the intravenous administration of diodrast. JAMA 1942;118:1051-2.
10. Naterman H, Robins S. Cutaneous test with diodrast to predict allergic systemic reactions. JAMA 1942;119:491-3.
11. Alyea E, Haines C. Intradermal test for sensitivity to iodopyracet injection or diodrast. JAMA 1947;135:25-7.
12. Lang J, Lasser E, Kolb W. Activation of serum complement by contrast media. Invest Radiol 1976;11:303-8.
13. Lasser EC, Lang JH, Lyon SG, Hamblin AE. Complement and contrast material reactors. J Allergy Clin Immunol 1979; 64:105-12.
14. Schneiderman H, Hammerschmidt D, Mc Call A, Jacob H. Fatal complement-induced leukostasis after diatrizoate injection. Principles of clinico-pathologic diagnosis. JAMA 1983;250:2340-2.
15. Eloy R, Corot C, Belleville J. Contrast media for angiography: physicochemical properties, pharmacokinetics and biocompatibility. Clin Mater 1991; 7:89-97.
16. Lieberman P. Anaphylactoid reactions to radiocontrast material. Clin Rev Allergy 1991;9:319-38.
17. Younger R, Herrod H, Lieberman P, Trouy R, Crawford L. Characteristics of diatrizoate-induced basophil histamine release. J Allergy Clin Immunol 1991; 77:94-100.
18. Stellato C, Adkinson N. Pathophysiology of contrast media anaphylactoid reactions: new perspectives on an old problem. Allergy 1998;53:1111-3.
19. Greenberger P. Contrast media reactions. J Allergy Clin Immunol 1984;74: 600-5.
20. Stellato C, De Crescenzo G, Patella V, Mastronardi P, Mazzarella B, Marone G. Human basophil/mast cell releasability. Heterogeneity of the effects of contrast media on mediator release. J Allergy Clin Immunol 1996;97:838-50.
21. Genovese A, Stellato C, Marsella C, Adt M, Marone G. Role of mast cells, basophils and their mediators in adverse reactions to general anesthetics and radiocontrast media. Int Arch Allergy Immunol 1996;110:13-22
22. Morcos S, Thomsen H, Webb J and the Contrast Media Safety Committee of the European Society of Urogenital Radiology. Prevention of generalized reactions to contrast media: a consensus report and guidelines. Eur. Radiol 2001; 11:1720-8.
23. Crepea S, Allanson J, Delambre L. The failure of antihistaminic drugs to inhibit diodrast reactions NY State JM 1949; 49:2556-8.
24. Schatz M, Patterson R, O' Rourke J, Nickelsen J, Northrup C. The administration of radiographic contrast media to patients with a history of a previous reaction. J Allergy Clin Immunol 1975;55: 358-66.
25. Zweiman G, Mishkin M, Hildreth E. An approach to the performance of radio-contrast studies in contrast material-reactive persons. Ann Intern Med 1975;83:159-62.
26. Bertrand P, Soyer P, Rouleau P, Alison D, Billardon M. Comparative randomized double-blind study of hydroxyzine versus placebo as premedication before injection of iodinated contrast media. Radiology 1992;184:383-4.
27. Greenberger P, Patterson R, Tapio, CM. Prophylaxis against repeated radiocontrast media reactions in 857 cases. Arch Intern Med 1985;145:2197-200.
28. Marshall G, Lieberman, PL. Comparison of three pretreatment protocols to prevent anaphylactoid reactions to radiocontrast media. Ann Allergy 1991;67: 70-4.
29. Lasser E, Berry, CC, Talner et al. Pre-treatment with corticosteroids to alleviate reactions to intravenous contrast material. N Engl J Med 1987;317:845-9.
30. Freed K, Leder R, Alexander C, DeLong D, Kliewer M. Breakthrough adverse reactions to low-osmolar contrast media after steroid premedication. AJR Am J Roentgenol 2001;176:1389-92.
31. Nilsson S, Bergstrand, L, Erikson, U, Johansson, J, Smedby, O, Walldius, G. Allergic reactions at repeat femoral angiography with ioxaglate. Acta Radiologica 2001;42:608-11.
32. Coste F, Tremolieres F, Bousquet M et al. Coagulation intra-vasculaire disséminée massive au cours d'une phlébographie. Responsabilité de l'acide ε amino-caproïque?. Presse Med 1985; 14:832-4.
33. Malinovsky JM, Pain L, Juvin P, Langeron O, Riou B, Martin C. Aide à la lecture d'une étude scientifique. Comité des référentiels cliniques de la Société Française d'Anesthésie et de Réanimation. Ann Fr Anesth Reanim 2000;19:209-16.
34. ANDEM. Recommandations pour l'emploi et le choix des différentes classes de produits de contraste iodés hydrosolubles lors des examens tomodensitométriques et urographiques. 1994.
35. Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1977; 1:466-9.
36. Alvarez-Fernandez J, Valero A, Pulido Z, De La Hoz B, Cuevas M, Sanchez-Cano M. Hypersensitivity reaction to ioversol. Allergy 2000;55:581-2.
37. Brown V, Brandner B, Brook J, Adiseshiah M. Cardiac arrest after administration of Omnipaque radiocontrast medium during endoluminal repair of abdominal aortic aneurysm. Br J Anaesth 2002;88:133-5.
38. Leynadier F. Réactions anaphylactoides des produits de contraste iodés. Rev Fr Allergol Immunol Clin 2002;42: 91-6.
39. Kanny G, Maria Y, Mentre B, Moneret-Vautrin D. Case report: recurrent anaphylactic shock to radiographic contrast media. Evidence supporting an exceptional IgE-mediated reaction. Allergol Immunol 1993;25:425-30.
40. Dewachter P, Mouton-Faivre C. Réactions sévères avec les produits de contraste iodés: l'anaphylaxie est-elle responsable? J Radiol 2001;82:973-7.
41. Dewachter P, Mouton-Faivre C, Felden F. Allergy and contrast media. Allergy 2001;56:250-1.
42. Moneret-Vautrin D, Kanny G, Morisset M, Beaudoin E, Renaudin J. Réactions anaphylactoides et cutanées tardives aux produits de contraste iodés: état actuel de la question-évolution des idées. Rev Med Interne 2001;22:969-77.
43. Miller S. Anaphylactoid reaction after oral administration of diatrizoate meglumine and diatrizoate sodium solution. Am J Roentgenol 1997;168:959-61.
44. Roberts M, Fisher M. Anaphylactoid reaction to iopamiron after pretreatment. Australas Radiol 1992;36:144-6.
45. Valfrey J, Newinger G, Arbogast R, Pauli G. Choc à l'ioxaglate (Hexabrix 320) lors de coronarographies. A propos de deux cas. Rev Fr Allergol Immunol Clin 2002;42:157-62.
46. Laxenaire M, Torrens J, Moneret-Vautrin D. Choc anaphylactoide mortel chez un malade traité par β-bloquants. Ann Fr Anesth Reanim 1984;3:453-5.
47. Brockow K, Vieluf D, Püschel K, Grosch J, Ring J. Increased post-mortem serum mast cell tryptase in a fatal anaphylactoid reaction to nonionic radiocontrast medium. J Allergy Clin Immunol 1999; 104:237-8.
48. Pumphrey R, Roberts I. Postmortem findings after fatal anaphylactic reactions. J Clin Pathol 2000;53:273-6.
49. Zuckerman GB, Riess PL, Patel L, Constantinescu AR, Rosenfeld DL. Development of a life-threatening reaction following administration of ioversol in a child. Pediatr Radiol 1999;29:295-7.
50. Laroche D, Aimone-Gastin I, Dubois F et al. Mechanisms of severe immediate reactions to iodinated contrast material. Radiology 1998;209:183-90.
51. Mita H, Tadokoro K, Akiyama K. Detection of IgE antibody to a radiocontrast medium. Allergy 1998;53:1133-40.
52. Mertes PM, Pinaud M. Quels sont les mécanismes en général? Comment expliquer les expressions cliniques gravissimes? Ann Fr Anesth Reanim 2002;21:55-72.
53. Malinovsky JM, Vervloet D, Laxenaire MC. Y a-t'-il des facteurs favorisant la réaction allergique, inhérents au terrain, aux médicaments, à la technique d'utilisation? Indications du bilan prédictif. Ann Fr Anesth Reanim 200221:129-50.
54. Dewachter P. La prévention du risque allergique peut-elle être assurée par une médication préanesthésique? Ann Fr Anesth Reanim 2002;21:151-67.
55. Bettmann M, Heeren T, Greenfield A, Goudey C for the SCVIR contrast agent registry investigators. Adverse events with radiographic contrast agents: results of the SCVIR contrast agent registry. Radiology 1997;203:611-20.
56. Coakley F, Panicek D. Iodine allergy: An oyster without a pearl? Am J Roentgenol 1997;169:951-2.
57. Kalsner S, Richards R. Coronary arteries of cardiac patients are hyperreactive and contain stores of amines: a mechanism for coronary spasm. Science 1984;223:1435-7.
58. Rodriguez R, Guéant J, Aimone-Gastin I et al. Comparison of effects of ioxaglate versus iomeprol on histamine and tryptase release in patients with ischemic cardiomyopathy. Am J Cardiol 2001;88:185-8.
59. Javeed N, Javeed H, Javeed S, Moussa G, Wong P, Rezai F. Refratory anaphylactoid shock potentiated by β-blockers. Cathet Cardiovasc Diagn 1996;39:383-4.
60. Lang D, Alpern M, Visintainer P, Smith S. Increased risk for anaphylactoid reaction from contrast media in patients on β-adrenergic blockers or with asthma. Ann Intern Med 1991;115: 270-6.
61. Yocum M, Khan D. Assessment of patients who have experienced anaphylaxis: A 3-years survey. Mayo Clin Proc 1994;69:16-23.
62. Thomas M, Koshi T, Korah I. Adverse reactions to radiocontrast media in an Indian population. Br J Radiol 1999;72:648-52.
63. Madowitz J, Schweiger M. Severe anaphylactoid reaction to radiographic contrast media. Recurrence despite premedication with diphenylhydramine and prednisone. JAMA 1979;241: 2813-5.
64. Siegle R, Halvorsen R, Dillon J, Gavant M, Halpern E. The use of iohexol in patients with previous reactions to ionic contrast material: a multicenter clinical trial. Invest Radiol 1991;26:411-6.
65. Cohan R, Matsumoto J, Quagliano P. ACR manual on contrast media. 4th ed. Reston, American College of Radiology 1998.
66. Douglas W. Histamine and 5-hydroxytryptamine (serotonin) and their antagonists. In: Gilman A, Goodman L, Rall T, Murad F, Eds. The pharmacologic basis of therapeutics. 7th ed. 1987.
67. Martinelli L, Maurelli M, Vigano M. Aprotinin in staged heart transplantation: anaphylactic potential of repeated exposure. Ann Thorac Surg 1996;61: 1288-9.
68. Brinkmann T, Korfer R, Wenzel H, Tsesche H, Kleesiek K. Strong cross-reaction to human anti-aprotinin antibodies from heart transplant patient with (Arg 15) aprotinin. Immunopharmacology 1997;35:221-8.
69. Dietrich W, Späth P, Ebell A, Richter J. Prevalence of two hundred forty-eight reexposures to aprotinin in heart operations. J Thorac Cardiovasc Surg 1997; 113:194-201.
70. Ryckwaert Y, Barthelet Y, Bonnet-Boyer M, Rochette A, Capdevilla X, d'Athis F. Choc anaphylactique après administration d'une dose-test d'aprotinine en chirurgie orthopédique infantile. Ann Fr Anesth Reanim 1999;18:904-8.
71. Cohen D, Norberto J, Cartabuke R, Ryu G. Severe anaphylactic reaction after primary exposure to aprotinin. Ann Thorac Surg 1999;67:837-8.
72. Pecquet C, Autegarden J, Kural-Menasche S et al. Réactions anaphylactiques à l'aprotinine: intérêt diagnostique des tests intradermiques. Ann Fr Anesth Reanim 2000;19:755-7.
73. Fischer H, Doust V. An evaluation of pretesting in the problem of serious and fatal reactions to excretory urography. Radiology 1972;103:497-501.
74. Cochran S, Bomyea K. Trends in adverse events after IV administration of contrast media [Reply]. Am J Roentgenol 2002;178:765-6.
75. Craft T. Torsades de pointes after astemizole overdose. Br Med J 1986;292: 660.
76. Bishop R, Gaudry P. Prolonged QT interval following astemizole overdose. Arch Emerg Med 1989;6:63-5.
77. Wiley J, Gelber M, Henretig F, Wiley C, Sandhu S, Loiselle J. Cardiotoxic effects of astemizole overdose in children. J Pediatr 1992;120:799-802.
78. Snook J, Boothman-Burrell D, Watkins J, Colin-Jones D. Torsades de pointes ventricular tachycardia associated with astemizole overdose. Br J Clin Pract 1988;42:257-9.
79. Leor J, Harman M, Rabinowitz B, Mozes B. Giant U waves and associated ventricular tachycardia complicating astemizole overdose: successful therapy with intravenous magnesium. Am J Med 1991;91:94-7.
80. Warin R. Torsades de pointes complicating treament with terfenadine. Br Med J 1991;303:58.
81. Simons F, Kesselman M, Giddins N, Pelech A, Simons K. Astemizole-induced torsades de pointes. Letter. Lancet 1988;2:624.
82. Monahan B, Ferguson C, Killeavy E, Lloyd B, Troy J, Cantilena L. Torsades de pointes occurring in association with terfenadine use. JAMA 1990;264: 2788-90.
83. Mac Connell T, Stanners A. Torsades de pointes complicating treatment with terfenadine. Br Med J 1991;302:1469.
84. Davies A, Harindra V, Mc Ewan A, Ghose R. Cardiotoxic effect with convulsions in terfenadine overdose. Br Med J 1989;298:325.
85. 1antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects. Clin Exp All 2002;32:489-98.
86. Hollister L. Hydroxyzine hydrochloride: possible adverse cardiac interactions. Psychopharmacology communications 1975;1:61-5.
87. Barranco P, Lopez-Serrano MC, Moreno-Ancillo A. Anaphylactic reaction due to diphenhydramine. Allergy 1998; 53:814.
88. Barry J, Madan R, Hewitt P. Anaphylactoid reaction to ranitidine in an obstetric patient. Anaesthesia 1992;47:360-1.
89. Greer I, Fellows K. Anaphylactoid reaction to ranitidine in labour. Br J Clin Pract 1990;44:78.
90. Powell J, Maycoock E. Anaphylactoid reaction to ranitidine in an obstetric patient. Anaesth Intensive Care 1993;21: 702-3.
91. 2-receptor antagonists. Letter. Lancet 1992;336:1366.
92. Lazaro M, Compaired J, De La Hoz B et al. Anaphylactic reaction to ranitidine. Allergy 1993;48:385-7.
93. Mira-Perceval J, Ortiz J, Sarrio F et al. Nizatidine anaphylaxis. J Allergy Clin Immunol 1996;97:855-6.
94. Picardo M, Santucci B. Urticaria from ranitidine. Contact dermatitis 1983; 9:327.
95. Iberti T, Paluch T, Helmer L, Murgolo V, Benjamin E. The hemodynamic effects of intravenous cimetidine in intensive care unit patients: a double-blind prospective study. Anesthesiology 1986;64: 87-9.
96. Kiowski W, Frei A. Bolus injection of cimetidine and hypotension in patients in the intensive care unit. Incidence and mechanisms. Arch Intern Med 1987; 147:153-6.
97. Smith C, Bardgett D, Hunter J. Haemodynamic effects of the i.v administration of cimetidine or ranitidine in the critically ill patient. A double-blind prospective study. Br J Anaesth 1987;59:1397-402.
98. Omote K, Namiki A, Nishikawa T, Hagiwara T, Iwasaki H, Tsuchida H. Haemodynamic effects of famotidine and cimetidine in critically ill patients. Acta Anaesthesiol Scand 1990;34:576-8.
99. Coursin D, Farin-Rusk C, Springman S, Goelzer S. The hemodynamic effects of intravenous cimetidine versus ranitidine in intensive care unit patients: a double-blind prospective cross-over study. Anesthesiology 1988;69:975-8.
100. Cohen J, Weetman A, Dargie H, Krikler D. Life-threatening arrhythmias and intravenous cimetidine. Br Med J 1979; 2:768.
101. Lineberger A, Sprague D, Battaglini J. Sinus arrest associated with cimetidine. Anesth Analg 1985;64:554-6.
102. 2 receptor. Nature 1973;244:287-8.
103. 2-receptor antagonists in the feedback of histamine. 5th Annual meeting of the European branch of the histamine Club, Paris 6-8 mai 1976.
104. Ting S, Zweiman B, Lavker R, Dunsky E. Histamine suppression of in vivo eosinophil accumulation and histamine release in human allergic reactions. J Allergy Clin Immunol 1981;68:65-71.
105. 2 receptor antagonists. Lancet 1982;ii:938-9.
106. Shaw R, Mashford M, Desmond P. Cardiac arrest after intravenous injection of cimetidine. Med J Aust 1980;2:629-30.
107. Mesurolle B, Ariche M, Cohen D. Pre-medication before i.v contrast-enhanced CT resulting in steroid-induced psychosis. Am J Roentgenol 2002;178: 766-7.
108. Roos W. Psychoses in cortisone therapy. Med Welt 1965;38:2167-71.
109. Delerue O, Muller J, Destee A, Warot P. Mania-like episodes associated with ranitidine. Am J Psychiatry 1988;145:271.